CN107678184A - 负离子医学眼镜 - Google Patents
负离子医学眼镜 Download PDFInfo
- Publication number
- CN107678184A CN107678184A CN201711061576.9A CN201711061576A CN107678184A CN 107678184 A CN107678184 A CN 107678184A CN 201711061576 A CN201711061576 A CN 201711061576A CN 107678184 A CN107678184 A CN 107678184A
- Authority
- CN
- China
- Prior art keywords
- medical science
- glasses
- anion
- powder
- picture frame
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011521 glass Substances 0.000 title claims abstract description 14
- 150000001450 anions Chemical class 0.000 title claims abstract description 13
- 210000001508 eye Anatomy 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 16
- 230000004060 metabolic process Effects 0.000 claims abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 11
- 239000001301 oxygen Substances 0.000 claims abstract description 11
- 229940070527 tourmaline Drugs 0.000 claims abstract description 11
- 229910052613 tourmaline Inorganic materials 0.000 claims abstract description 11
- 239000011032 tourmaline Substances 0.000 claims abstract description 11
- 206010058490 Hyperoxia Diseases 0.000 claims abstract description 8
- 239000002131 composite material Substances 0.000 claims abstract description 8
- 230000000222 hyperoxic effect Effects 0.000 claims abstract description 8
- -1 oxygen ion Chemical class 0.000 claims abstract description 8
- 230000004087 circulation Effects 0.000 claims abstract description 7
- 150000002500 ions Chemical class 0.000 claims abstract description 5
- 230000033228 biological regulation Effects 0.000 claims abstract description 4
- 230000004438 eyesight Effects 0.000 claims description 8
- 230000004913 activation Effects 0.000 claims description 7
- 239000003053 toxin Substances 0.000 claims description 7
- 231100000765 toxin Toxicity 0.000 claims description 7
- 230000004313 glare Effects 0.000 claims description 6
- 210000004204 blood vessel Anatomy 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 229910052684 Cerium Inorganic materials 0.000 claims description 3
- 229910052779 Neodymium Inorganic materials 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 238000005242 forging Methods 0.000 claims description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 3
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052746 lanthanum Inorganic materials 0.000 claims description 3
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000011858 nanopowder Substances 0.000 claims description 3
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000011069 regeneration method Methods 0.000 claims description 3
- 239000011435 rock Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000004575 stone Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000010936 titanium Substances 0.000 claims description 3
- 229910052727 yttrium Inorganic materials 0.000 claims description 3
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 3
- 230000001413 cellular effect Effects 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 230000003667 anti-reflective effect Effects 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 230000006378 damage Effects 0.000 abstract description 5
- 208000027418 Wounds and injury Diseases 0.000 abstract description 4
- 208000014674 injury Diseases 0.000 abstract description 4
- 208000009115 Anorectal Malformations Diseases 0.000 abstract description 3
- 206010007772 Cataract conditions Diseases 0.000 abstract description 3
- 206010025421 Macule Diseases 0.000 abstract description 3
- 210000000695 crystalline len Anatomy 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 7
- 208000001491 myopia Diseases 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000004379 myopia Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 206010001513 AIDS related complex Diseases 0.000 description 2
- 208000022873 Ocular disease Diseases 0.000 description 2
- 206010043189 Telangiectasia Diseases 0.000 description 2
- 210000002945 adventitial reticular cell Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000009056 telangiectasis Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000030768 Optic nerve injury Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 208000034699 Vitreous floaters Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000008336 microcirculatory blood flow Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/44—Applying ionised fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C11/00—Non-optical adjuncts; Attachment thereof
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/10—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Abstract
负离子医学眼镜,它涉及医学眼镜技术领域;它包含镜腿、镜框、镜片和鼻托;所述的镜框内均布有能够释放负氧离子和远红外线的纳米电气石粉;所述的镜腿和鼻托内均布有高氧复合粉末,能够促进血液循环,调节人体代谢,消除疲劳,调节人体正负离子平衡;所述的镜片上设置有EMI膜,有效过滤蓝光和紫外线。本发明所述的负离子医学眼镜,100%阻止电子产品LED光线释放的蓝光,防止蓝光破坏眼睛的视网膜黄斑区,避免在昏暗环境中使用手机,平板电脑等设备而患上黄斑病变眼科疾病;防止电子产品所释放的辐射波而导致眼睛的疲劳和干涩;防止周边UV紫外线的伤害而造成晶状体退化和硬化而过早患上白内障疾病。
Description
技术领域
本发明涉及医学眼镜技术领域,具体涉及负离子医学眼镜。
背景技术
在我国0到6岁的孩子中有66%从四岁开始接触电子产品,每天玩平板电脑和手机的时间是1.5~2小时。眼科专家表示,高能蓝光会对眼睛造成不可逆的伤害。实验表明,孩子在长时间使用电子产品后会明显感觉眼睛疲劳,查其视力都有不同程度的下降,一个正常视力的孩子,在连续使用平板电脑或手机半个小时后,他的视力水平在视力表上就会上升了一排,这说明视力在朝近视方向移动,中国目前有4亿儿童是近视!90%的眼睛疾病是因缺氧(氧气不足)所导致的,因为角膜没有血管、没有毛孔,湿润眼球全靠眨眼,但过度用眼造成干眼症、眼疲劳、视线模糊、引起视力下降,进而形成近视、散光。
人体的新陈代谢,会产生大量的代谢垃圾“自由基”,正是我们通说的“毒素”。眼部的衰老、退化、药物残留中毒及长期用眼疲劳,毒素就会大量产生。根据眼科专家的实验分析和对比发现:眼病患者眼晴中的“自由基”(毒素)含量,是正常人的100倍以上!静脉窦(眼筛)过滤毒素的速度比健康人慢10-20倍,大量自由基的存在,严重破坏眼部生理结构和视角神经,造成蛋白变异、代谢紊乱、视神经受损,形成眼压高,患青光眼、白内障、视力减退、飞蚊症和近视等各种眼病。严重影响患者的健康和视力,及早清除眼部的自由基,对眼睛排毒是眼病患者的当务之急,也是治疗眼病的根本。
发明内容
本发明的目的在于针对现有技术的缺陷和不足,提供一种具有防蓝光、防辐射、防紫外线功能的负离子医学眼镜。
为实现上述目的,本发明采用的技术方案是:它包含镜腿、镜框、镜片和鼻托;所述的镜框内均布有能够释放负氧离子和远红外线的纳米电气石粉;所述的镜腿和鼻托内均布有高氧复合粉末,能够促进血液循环,调节人体代谢,消除疲劳,调节人体正负离子平衡;所述的镜片上设置有EMI膜,有效过滤蓝光和紫外线。
作为优选,所述的纳米电气石粉为麦饭石、火山岩、赭石和托玛琳纳米粉末,采用量子舱植入量子能量工艺注入镜框,高温锻造而成。
作为优选,所述的高氧复合粉末为钙、磷、铈、钛、钇、钕、镧和锗粉末,经烘烤、冷却、搅拌而成。
作为优选,所述的镜片上还设置有AR抗反射涂层,能够清除镜面的漫反射,有效消除杂光和炫光。
作为优选,所述的远红外线能使眼部的毛细血管扩张,促进血液循环,加速代谢和排毒,有利于清除血管囤积物及体内有害物质,达到活化组织细胞加快新陈代谢,增加细胞组织的再生能力。
作为优选,所述的负氧离子使水分子产生共振激活变成独立水分子,提高细胞血液中的含氧量,增强眼球细胞活力因而能恢复眼睛健康,提高视力。
采用上述结构后,本发明产生的有益效果为:本发明所述的负离子医学眼镜,100%阻止电子产品LED光线释放的蓝光,防止蓝光破坏眼睛的视网膜黄斑区,避免在昏暗环境中使用手机,平板电脑等设备而患上黄斑病变眼科疾病;防止电子产品所释放的辐射波而导致眼睛的疲劳和干涩;防止周边UV紫外线的伤害而造成晶状体退化和硬化而过早患上白内障疾病。
附图说明
图1是本发明的结构图;
图2是图1中的A部结构图;
图3是图1中的B部结构图;
图4是图1中的C部结构图。
附图标记说明:
镜腿1、镜框2、镜片3、鼻托4、纳米电气石粉5、高氧复合粉末6。
具体实施方式
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其他的附图。
参看如图1——图4所示,本具体实施方式采用如下技术方案:它包含镜腿1、镜框2、镜片3和鼻托4;所述的镜框2内均布有能够释放负氧离子和远红外线的纳米电气石粉5;所述的镜腿1和鼻托4内均布有高氧复合粉末6,能够促进血液循环,调节人体代谢,消除疲劳,调节人体正负离子平衡;所述的镜片3上设置有EMI膜,有效过滤蓝光和紫外线。
所述的纳米电气石粉5为麦饭石、火山岩、赭石和托玛琳纳米粉末,采用量子舱植入量子能量工艺注入镜框2,高温锻造而成,每立方厘米能释放1100—1700负氧离子。
所述的高氧复合粉末6为钙、磷、铈、钛、钇、钕、镧和锗粉末,经烘烤、冷却、搅拌而成。
所述的镜片上还设置有AR抗反射涂层,能够清除镜面的漫反射,有效消除杂光和炫光。
所述的远红外线被人体吸收后,可使体内水分子产生共振,使水分子活化,使生物体细胞处于最高振动能级。能使眼部的毛细血管扩张,促进血液循环,有利于清除血管囤积物及体内有害物质,达到活化组织细胞加快新陈代谢,增加细胞组织的再生能力。(根据中国医学科学院血液病研究所检测,人体经过红外线照射20分钟可使微循环血流量提高114%)。可以快速排出眼部的毒素,增强细胞的活力,使用简单方便,无药物残留,无副作用。
所述的负氧离子使水分子产生共振激活变成独立水分子(即两个氢分子和一个氧分子结合),提高细胞血液中的含氧量,增强眼球细胞活力因而能恢复眼睛健康,提高视力。
采用上述结构后,本具体实施方式产生的有益效果为:本具体实施方式所述的负离子医学眼镜,100%阻止电子产品LED光线释放的蓝光,防止蓝光破坏眼睛的视网膜黄斑区,避免在昏暗环境中使用手机,平板电脑等设备而患上黄斑病变眼科疾病;防止电子产品所释放的辐射波而导致眼睛的疲劳和干涩;防止周边UV紫外线的伤害而造成晶状体退化和硬化而过早患上白内障疾病。
以上显示和描述了本发明的基本原理和主要特征以及本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (6)
1.负离子医学眼镜,其特征在于:它包含镜腿、镜框、镜片和鼻托;所述的镜框内均布有能够释放负氧离子和远红外线的纳米电气石粉;所述的镜腿和鼻托内均布有高氧复合粉末,能够促进血液循环,调节人体代谢,消除疲劳,调节人体正负离子平衡;所述的镜片上设置有EMI膜,有效过滤蓝光和紫外线。
2.根据权利要求1所述的负离子医学眼镜,其特征在于:所述的纳米电气石粉为麦饭石、火山岩、赭石和托玛琳纳米粉末,采用量子舱植入量子能量工艺注入镜框,高温锻造而成。
3.根据权利要求1所述的负离子医学眼镜,其特征在于:所述的高氧复合粉末为钙、磷、铈、钛、钇、钕、镧和锗粉末,经烘烤、冷却、搅拌而成。
4.根据权利要求1所述的负离子医学眼镜,其特征在于:所述的镜片上还设置有AR抗反射涂层,能够清除镜面的漫反射,有效消除杂光和炫光。
5.根据权利要求1所述的负离子医学眼镜,其特征在于:所述的远红外线能使眼部的毛细血管扩张,促进血液循环,加速代谢和排毒,有利于清除血管囤积物及体内有害物质,达到活化组织细胞加快新陈代谢,增加细胞组织的再生能力。
6.根据权利要求1所述的负离子医学眼镜,其特征在于:所述的负氧离子使水分子产生共振激活变成独立水分子,提高细胞血液中的含氧量,增强眼球细胞活力因而能恢复眼睛健康,提高视力。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711061576.9A CN107678184A (zh) | 2017-11-02 | 2017-11-02 | 负离子医学眼镜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711061576.9A CN107678184A (zh) | 2017-11-02 | 2017-11-02 | 负离子医学眼镜 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107678184A true CN107678184A (zh) | 2018-02-09 |
Family
ID=61144786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711061576.9A Pending CN107678184A (zh) | 2017-11-02 | 2017-11-02 | 负离子医学眼镜 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107678184A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109737511A (zh) * | 2018-12-29 | 2019-05-10 | 深圳我氧你绿色科技有限公司 | 一种释放负离子抗菌除异味的家用空调口罩 |
CN110031985A (zh) * | 2018-12-20 | 2019-07-19 | 陆金成 | 一种负离子石墨烯防蓝光眼镜及其制作方法 |
CN110200744A (zh) * | 2019-06-04 | 2019-09-06 | 苏州科技大学 | 一种小型化负离子护目眼镜的设计制备方法及负离子护目眼镜 |
CN110575372A (zh) * | 2019-08-19 | 2019-12-17 | 天狼联盟材料科技研究(广东)有限公司 | 一种利用光频预防青少年弱视的系统与装备 |
-
2017
- 2017-11-02 CN CN201711061576.9A patent/CN107678184A/zh active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110031985A (zh) * | 2018-12-20 | 2019-07-19 | 陆金成 | 一种负离子石墨烯防蓝光眼镜及其制作方法 |
CN109737511A (zh) * | 2018-12-29 | 2019-05-10 | 深圳我氧你绿色科技有限公司 | 一种释放负离子抗菌除异味的家用空调口罩 |
CN110200744A (zh) * | 2019-06-04 | 2019-09-06 | 苏州科技大学 | 一种小型化负离子护目眼镜的设计制备方法及负离子护目眼镜 |
CN110575372A (zh) * | 2019-08-19 | 2019-12-17 | 天狼联盟材料科技研究(广东)有限公司 | 一种利用光频预防青少年弱视的系统与装备 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103167850B (zh) | 利用离子透入角膜传输核黄素治疗圆锥角膜的装置 | |
CN107678184A (zh) | 负离子医学眼镜 | |
US10835417B2 (en) | Devices and methods for novel retinal irradiance distribution modification to improve and restore vision without producing corneal vitrification | |
CN101822872A (zh) | 一种眼近红外光治疗仪 | |
WO2010003327A1 (zh) | 用于治疗眼科视力障碍疾病的增视仪 | |
CN107300784A (zh) | 量子生物镜框及使用该镜框的量子生物眼镜 | |
MX2014004297A (es) | Composicion reticuladora mejorada, suministrada por iontoforesis, util para el tratamiento de queratocono. | |
CN108873381A (zh) | 医学保健眼镜 | |
RU2510258C1 (ru) | Способ лечения эктатических заболеваний роговицы | |
CN213252615U (zh) | 一种具有缓解近视疲劳的高红光结构及眼部理疗器 | |
RU2280425C1 (ru) | Способ лечения глазных заболеваний с помощью аппарата "око-медиус" | |
CN103340992A (zh) | 一种调整视力的眼帖膏 | |
CN107050226A (zh) | 一种治疗眼部视疲劳疾病的中药眼敷组合膏剂及制备方法 | |
RU2495669C1 (ru) | Способ лечения дегенеративных и дистрофических заболеваний сетчатки | |
CN105902686A (zh) | 一种含有纳米碳晶的原位凝胶眼药水及其制备方法 | |
KR101880753B1 (ko) | 안대의 한약 조성물 | |
CN103948633A (zh) | 一种治疗眼病的滴眼液及其制备方法 | |
CN108498615A (zh) | 一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法 | |
RU2460502C1 (ru) | Способ лечения возрастной начинающейся катаракты | |
CN105998755A (zh) | 治疗近视弱视用温灸药物及温灸装置 | |
CN2802542Y (zh) | 理疗镜 | |
CN208710818U (zh) | 一种负离子舒缓眼镜 | |
RU2611951C1 (ru) | Способ стабилизации кератоконуса терапевтическими средствами | |
RU2173120C1 (ru) | Способ лечения дистрофических и воспалительных заболеваний заднего отдела глаза | |
RU2161465C1 (ru) | Способ повышения остроты зрения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180209 |